Vivien A Sheehan MD PhD

PubMed

• Altered nasal and oral microbiomes define pediatric sickle cell disease.
  Audra L Crouch, Beatrice M Severance, Susan Creary, Darryl Hood, Michael Bailey
  Msphere. 2025-05-14
• Use of the Microfluidic Impedance Red Cell Assay (MIRCA) in Sickle Cell Disease.
  Akshay Amit Patwardhan, Ashwin P Patel, Abhinav K Pasupuleti, Solomon Oshabaheebwa, Christopher A Delianides
  Blood Advances. 2025-05-01
• Impact of hydroxycarbamide treatment on the whole-blood transcriptome in sickle cell disease.
  Varsha Bhat, Alka A Potdar, G Karen Yu, Greg Gibson, Vivien A Sheehan
  British Journal of Haematology. 2025-02-01

Abstracts/Posters

• Association between GLUT1 and HbF Levels in Red Blood Cells from Patients with Sickle Cell Disease
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Rheological Effects of L-Glutamine in Patients with Sickle Cell Disease
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Plasma BDNF Levels Are Associated with Stroke in Children with SCD
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Regulation of Fetal Hemoglobin through the Insulin Signaling Pathway
  Vivien A. Sheehan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Metformin Induces FOXO3-Dependent Fetal Hemoglobin Production in Human Primary Erythroid Cells
  Vivien Sheehan, MD, Blood, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Highly Efficient Editing of the Beta-Globin Gene in Patient Derived Hematopoietic Stem and Progenitor Cells to Treat Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Surgical Splenectomy Alters Red Cell Rheology in Patients with Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018